T1	Qualifier 15 26	stable dose
T2	Temporal 55 91	at least 3 months prior to screening
T3	Drug 109 136	immediate-release metformin
T4	Value 95 108	>=1000 mg/day
T5	Drug 141 150	metformin
R1	Has_temporal Arg1:T1 Arg2:T2	
T6	Value 151 164	>=1000 mg/day
T7	Drug 169 181	sulfonylurea
T8	Drug 186 198	sulfonylurea
T9	Drug 199 208	metformin
T10	Procedure 209 228	combination therapy
R2	AND Arg1:T6 Arg2:T5	
T11	Scope 141 181	metformin >=1000 mg/day and sulfonylurea
R3	AND Arg1:T10 Arg2:T9	
R4	AND Arg1:T10 Arg2:T8	
R5	AND Arg1:T4 Arg2:T3	
*	OR T3 T11 T10
T12	Scope 95 228	>=1000 mg/day immediate-release metformin; or metformin >=1000 mg/day and sulfonylurea; or sulfonylurea/metformin combination therapy
R6	Has_qualifier Arg1:T12 Arg2:T1	
T13	Measurement 231 236	HbA1c
T14	Value 237 270	between 7.1% and 11.0%, inclusive
T15	Measurement 273 294	Body Mass Index (BMI)
T16	Value 295 320	>21 kg/m^2 and <35 kg/m^2
R7	Has_value Arg1:T15 Arg2:T16	
R8	Has_value Arg1:T13 Arg2:T14	
T17	Reference_point 82 91	screening
R9	Has_index Arg1:T2 Arg2:T17	
T18	Multiplier 30 50	one of the following
R10	Has_multiplier Arg1:T12 Arg2:T18	
